WBD Posts Earnings Beat, But CEO Selling and Analyst Caution Persist
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Warner Bros. Discovery delivered a positive earnings surprise on August 6 — the stock added 3.1% on the day — yet the backdrop heading into the next quarter retains the same uncomfortable undertow that dominated pre-print coverage.
The most striking feature of the post-earnings week is how little the options market has changed its tone. Put/call activity has turned meaningfully less defensive since the print: the ratio dropped to 1.85 on August 7, nearly three standard deviations below its 20-day average of 1.99. That's the sharpest swing toward calls seen in the recent history. But context matters here — WBD's PCR has run persistently elevated for months, and even after the shift it remains well above 1.5, meaning puts still dominate the options book by a wide margin. The market has exhaled, not relaxed.
The lending market tells a similarly uncrowded story. Borrow availability is extraordinarily loose at 8,269% — roughly 83 shares available for every one currently lent out — making WBD one of the easiest large-cap media names to borrow in the entire market. Short interest at 2.59% of free float is marginal and continues to drift lower, down about 3% over the past month after a sharper 14% decline in the prior week. Cost to borrow at 0.41% is negligible. The ORTEX short score has nudged down again, from 33.5 a fortnight ago to 33.1 now — a low absolute reading that signals no meaningful short-side conviction. There is simply no evidence of shorts rebuilding after the print.
The Street remains cautious on fundamentals. Sixteen analysts hold a neutral rating; only two are buyers. The mean price target of $29.82 implies modest upside from the $26.78 close, but the consensus has been sticky rather than improving. The most recent rating action — Seaport Global's David Joyce downgrading back to Neutral on July 27, less than a month after upgrading to Buy — illustrates the difficulty of sustaining conviction on this name. Factor scores are a mixed signal: the stock ranks in the 97th percentile on EPS surprise and 99th for 90-day EPS momentum, which confirms the beat was genuine. But 12-month forward EPS growth ranks just 22nd percentile, and analyst recommendation sentiment sits near the bottom of the distribution at the 4th percentile. The EV/EBITDA of 11.4x has barely budged in 30 days. Bulls anchor on the streaming expansion story and the pending Paramount-Skydance acquisition upside; bears point to regulatory uncertainty around the deal and ongoing weakness in linear advertising.
The insider picture is the most persistent negative signal and has not improved post-earnings. CEO David Zaslav sold $59 million in shares on July 13 — at $27.22, well above the current price. That followed a $5.5 million sale in June. Net insider selling across the past 90 days totals approximately $71 million with zero offsetting purchases from any executive. The pattern is not ambiguous. Insiders were reducing exposure into a print they presumably had visibility on, and the stock has since traded below every recent sale price.
What to watch from here: the next earnings event is scheduled for November 6, giving a long runway before the next forced catalyst — the key variable in the intervening period is whether the Paramount-Skydance deal generates any regulatory news that shifts the analyst consensus from its deeply sceptical 16-hold posture.
Stocks in this article
See the live data behind this article on ORTEX.
Open WBD on ORTEX →How this article was generated
- Generated
- 8 Aug 2026, 20:47
- Data as of
- 8 Aug 2026, 20:47
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.